Skip to content

Clinical trials

Terminated Fallopian Tube Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Status: Terminated Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20043
20051
20069
20077
20084
20094
20107
20117
20124
20134
20142
20155
20162
20177
20185
20197
20203
20214
20228
20234
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated107

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
Gynecologic Oncology Group6
Masonic Cancer Center, University of Minnesota6
Dana-Farber Cancer Institute5
M.D. Anderson Cancer Center5
Abramson Cancer Center at Penn Medicine3
Pfizer3
Vanderbilt-Ingram Cancer Center3
Amgen2
Beth Israel Deaconess Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms107
Ovarian Neoplasms94
Carcinoma, Ovarian Epithelial38
Carcinoma, Non-Small-Cell Lung13
Endometrial Neoplasms10
Triple Negative Breast Neoplasms9
Recurrence8
Breast Neoplasms7
Neoplasms7
Brenner Tumor6

Trials

Showing 51 to 75 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.